2008
DOI: 10.1186/1472-6947-8-1
|View full text |Cite
|
Sign up to set email alerts
|

A decision-analytic approach to define poor prognosis patients: a case study for non-seminomatous germ cell cancer patients

Abstract: Background: Classification systems may be useful to direct more aggressive treatment to cancer patients with a relatively poor prognosis. The definition of 'poor prognosis' often lacks a formal basis. We propose a decision analytic approach to weigh benefits and harms explicitly to define the treatment threshold for more aggressive treatment. This approach is illustrated by a case study in advanced testicular cancer, where patients with a high risk of mortality under standard treatment may be eligible for high… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
32
0

Year Published

2009
2009
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 48 publications
(34 citation statements)
references
References 39 publications
2
32
0
Order By: Relevance
“…1031219-2). Subsequent to this certification, free-text fields were scanned for personal information using a previously published rule-based approach 10 . Briefly, this approach scans text for known patterns indicating presence of PHI (e.g.…”
Section: Methodsmentioning
confidence: 99%
“…1031219-2). Subsequent to this certification, free-text fields were scanned for personal information using a previously published rule-based approach 10 . Briefly, this approach scans text for known patterns indicating presence of PHI (e.g.…”
Section: Methodsmentioning
confidence: 99%
“…due to toxicity of treatment) is assumed to be constant at 4%. Net benefit occurs only when the cancer-specific mortality given standard treatment is above the threshold of 11% 451 (2) Check assumptions of relative benefit and absolute harm: subgroup effects of treatment may exist, both for benefit and harm, which invalidate the simple decision-analytic model in Fig. 2.3 .…”
Section: Intensity Of Treatmentmentioning
confidence: 99%
“…451 Several non-randomized trials reported a higher survival for patients treated with HD-CT as first line treatment (including etoposide, ifosfamide, cisplatin) with autologous stem cell support, compared to standard-dose (SD) chemotherapy (including bleomycin, etoposide, cisplatin). However, HD-CT is related to a higher toxicity, both during treatment (e.g.…”
Section: *236 Example: Defining a Poor Prognosis Subgroup In Cancermentioning
confidence: 99%
“… 1 This phenomenon of information overload has been observed in several care settings, from outpatient clinics to hospital admissions and the emergency department (ED). 2–4 With the advent of health information exchange, review of patient data will only become more complex and time consuming. 5 , 6 One of the promises of the electronic health record (EHR) is to support clinicians at the point of patient care.…”
Section: Background and Significancementioning
confidence: 99%